By Josh White
Date: Monday 23 Jun 2025
(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational treatment for cholestatic pruritus in patients with primary biliary cholangitis (PBC).
By Benjamin Chiou
Date: Friday 20 Jun 2025
(Sharecast News) - Japanese regulators have accepted GSK's application to expand the use of its RSV vaccine, Arexvy, to the entire adult population.
By Iain Gilbert
Date: Friday 13 Jun 2025
(Sharecast News) - Drugmaker GSK said on Friday that its RSV vaccine, Arexvy, has been accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and older.
Currency | UK Pounds |
Share Price | 1,395.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1,671.00p |
52 Week Low | 1,264.00p |
Volume | 0 |
Shares Issued | 4,087.27m |
Market Cap | £57,038m |
RiskGrade | 129 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 2 |
Neutral | 16 |
Sell | 3 |
Strong Sell | 0 |
Total | 24 |
Latest | Previous | |
---|---|---|
Q1 | Q4 | |
Ex-Div | 15-May-25 | 20-Feb-25 |
Paid | 10-Jul-25 | 10-Apr-25 |
Amount | 16.00p | 16.00p |
You are here: research